Robert J Terifay - Net Worth and Insider Trading
Robert J Terifay Net Worth
The estimated net worth of Robert J Terifay is at least $21 Million dollars as of 2024-11-13. Robert J Terifay is the EVP Commercial of Regeneron Pharmaceuticals Inc and owns about 24,992 shares of Regeneron Pharmaceuticals Inc (REGN) stock worth over $21 Million. Details can be seen in Robert J Terifay's Latest Holdings Summary section.
Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the final shares held after open market or private purchases and sales of common stock with a transaction code of "P" or "S" on Form 4, assuming that Robert J Terifay has not made any transactions after 2017-06-16 and currently still holds the listed stock(s). Please note that this estimate may not reflect the actual net worth.
Transaction Summary of Robert J Terifay
Robert J Terifay Insider Ownership Reports
Based on ownership reports from SEC filings, as the reporting owner, Robert J Terifay owns 1 companies in total, including Regeneron Pharmaceuticals Inc (REGN) .
Click here to see the complete history of Robert J Terifay’s form 4 insider trades.
Insider Ownership Summary of Robert J Terifay
| Ticker | Comapny | Transaction Date | Type of Owner |
|---|---|---|---|
| REGN | Regeneron Pharmaceuticals Inc | 2017-06-16 | SVP & Commercial |
Robert J Terifay Latest Holdings Summary
Robert J Terifay currently owns a total of 1 stock. Robert J Terifay owns 24,992 shares of Regeneron Pharmaceuticals Inc (REGN) as of June 16, 2017, with a value of $21 Million.
Latest Holdings of Robert J Terifay
| Ticker | Comapny | Latest Transaction Date | Shares Owned | Current Price ($) | Current Value ($) |
|---|---|---|---|---|---|
| REGN | Regeneron Pharmaceuticals Inc | 2017-06-16 | 24,992 | 821.00 | 20,518,432 |
Holding Weightings of Robert J Terifay
Robert J Terifay Form 4 Trading Tracker
According to the SEC Form 4 filings, Robert J Terifay has made a total of 0 transactions in Regeneron Pharmaceuticals Inc (REGN) over the past 5 years. The most-recent trade in Regeneron Pharmaceuticals Inc is the sale of 21,147 shares on June 16, 2017, which brought Robert J Terifay around $10 Million.
Insider Trading History of Robert J Terifay
- 1
Robert J Terifay Trading Performance
Robert J Terifay Ownership Network
Ownership Network List of Robert J Terifay
Ownership Network Relation of Robert J Terifay
Robert J Terifay Owned Company Details
What does Regeneron Pharmaceuticals Inc do?
Who are the key executives at Regeneron Pharmaceuticals Inc?
Robert J Terifay is the SVP & Commercial of Regeneron Pharmaceuticals Inc. Other key executives at Regeneron Pharmaceuticals Inc include SVP Commercial Marion Mccourt , VP & Controller Christopher R. Fenimore , and EVP Research Andrew J Murphy .
Regeneron Pharmaceuticals Inc (REGN) Insider Trades Summary
Over the past 18 months, Robert J Terifay made no insider transaction in Regeneron Pharmaceuticals Inc (REGN). Other recent insider transactions involving Regeneron Pharmaceuticals Inc (REGN) include a net sale of 10,814 shares made by Marion Mccourt , a net sale of 1,400 shares made by Arthur F Ryan , and a net sale of 7,918 shares made by Bonnie L Bassler .
In summary, during the past 3 months, insiders sold 26,837 shares of Regeneron Pharmaceuticals Inc (REGN) in total and bought 0 shares, with a net sale of 26,837 shares. During the past 18 months, 315,919 shares of Regeneron Pharmaceuticals Inc (REGN) were sold and 0 shares were bought by its insiders, resulting in a net sale of 315,919 shares.
Regeneron Pharmaceuticals Inc (REGN)'s detailed insider trading history can be found in Insider Trading Tracker table.
Regeneron Pharmaceuticals Inc Insider Transactions
Robert J Terifay Mailing Address
Above is the net worth, insider trading, and ownership report for Robert J Terifay. You might contact Robert J Terifay via mailing address: Regeneron Pharmaceuticals, Inc., 777 Old Saw Mill River Road, Tarrytown Ny 10591.
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
